Shanghai - Delayed Quote CNY
Dizal (Jiangsu) Pharmaceutical Co., Ltd. (688192.SS)
57.69
+0.26
+(0.45%)
At close: 3:00:03 PM GMT+8
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
1,496,378.57
2,081,908.06
2,745,757.18
1,215,318.10
Total Liabilities Net Minority Interest
647,751.15
323,427.02
282,911.21
136,407.98
Total Equity Gross Minority Interest
848,627.42
1,758,481.04
2,462,845.98
1,078,910.12
Total Capitalization
986,940.71
1,758,481.04
2,462,845.98
1,078,910.12
Common Stock Equity
848,627.42
1,758,481.04
2,462,845.98
1,078,910.12
Capital Lease Obligations
48,894.49
63,932.25
70,924.74
16,121.33
Net Tangible Assets
386,648.23
1,266,457.11
1,987,949
572,663.79
Working Capital
461,925.80
1,224,683.35
1,900,350.98
504,623.77
Invested Capital
1,187,055.67
1,758,481.04
2,462,845.98
1,078,910.12
Tangible Book Value
386,648.23
1,266,457.11
1,987,949
572,663.79
Total Debt
410,370.91
85,272.08
87,763.62
33,302.15
Net Debt
264,226.68
--
--
--
Share Issued
408,151.37
407,160.30
404,183.12
360,000
Ordinary Shares Number
408,151.37
407,160.30
404,183.12
360,000
12/31/2020 - 12/10/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade